Shandong Chenghui Shuangda Pharmaceutical Co., Ltd. was approved to build Dezhou antiviral drug technology innovation centre

Chenghui Shuangda

Recently, Dezhou Science and Technology Bureau issued a ‘notice on the approval of the construction of the 2024 annual Dezhou Science and Technology Innovation Platform’ Deke word [2024] No. 98, the construction of the list, our company declared the Dezhou antiviral drug technology innovation centre successfully selected, this good news is not only the company's technology research and development and innovation capabilities, but also the incentive for the future development of the ChengHuiShuangDa Pharmaceutical incentive and encouragement.

The next step, the company will take this opportunity to deeply implement the innovation-driven development strategy, to technological innovation as the core, to further enhance the ability of independent innovation, and continue to explore the landing of new technologies, new products, in order to promote the technological progress of the pharmaceutical industry, socio-economic development to contribute to the strength of ChengHui.